MMP7 and plasma cell myeloma: A significant increase in tumor burden in myeloma-bearing MMP-7−/− mice was demonstrated by an increase in myeloma-specific IgG2bκ serum concentrations and GFP-positive myeloma cells in the bone marrow and spleen, as compared to myeloma-bearing WT mice (Fig. 1a and b).